Spinal Tech

Bioventus has filed for an initial public stock offering, according to The News & Observer.

During the first quarter of 2016, NuVasive's institutional sentiment fell to 1.17, accord to Press Telegraph.

Someone always has to do it first, so neurosurgeon Juan Torres-Reveron, MD, PhD, of Premier Health's Miami Valley Hospital in Dayton, Ohio, volunteered to take that leap of faith into the realm of robotic-guided spine surgery.

Amendia named Chris Fair president and CEO.

Here are 15 key notes on orthopedic and spine device companies over the past week.

San Diego-based NuVasive settled its patent litigation with Dublin, Ireland-based Medtronic.

The global minimally invasive surgical instrument market is anticipated to grow at a compound annual growth rate of 10.2 percent through 2021, based on a MarketsandMarkets report, according to HealthCareBusiness.

Warren, N.J.-based Prosidyan and Rolla, Mo.-based MO-SCI partnered to help develop a new orthopedic technology involving boron-based bioactive glass materials.

Carlsbad, Calif.-based Aurora Spine granted stock options to acquire 1 million common shares of the company to the chairman of the company's board of directors, according to MarketWatch.

The percentage of physicians taking payments from pharmaceutical and medical device company varies in accordance with hospital location and ownership, according to a ProPublica report.